Return to Publications
September 2018
RWJBarnabas HealthRutgers Cancer Institute, along with its partner RWJBarnabas Health, offers the most advanced cancer treatment options including clinical trials and novel therapeutics such as precision medicine and immunotherapy.
Rutgers Cancer Institute

Reaffirming our Role as a Nationally Recognized Statewide Resource

Rutgers Cancer Institute of New Jersey, the state's only Comprehensive Cancer Center as designated by the National Cancer Institute (NCI), has successfully renewed this designation and remains one of the nation's top cancer centers. This prestigious designation is granted competitively to institutions characterized by the highest level of scientific excellence in cancer research and the ability to translate those discoveries to patients through novel treatments and clinical practice. There are only 49 NCI-designated Comprehensive Cancer Centers in the country and Rutgers Cancer Institute remains New Jersey's only such center. The NCI recognized Rutgers Cancer Institute's value as a collaborative matrix/consortium cancer center with Rutgers and Princeton Universities, as well as its commitment to cancer prevention, education and outreach.

Embrace Kids

$1 Million Commitment from Embrace Kids Foundation Supports Research Faculty

Thanks to a $1 million commitment from Embrace Kids Foundation that will support the recruitment of pediatric cancer research faculty, Rutgers Cancer Institute now has additional resources in the fight against pediatric cancers and blood disorders. Rutgers Cancer Institute Chief of Pediatric Hematology/ Oncology Peter D. Cole, MD, who is also a professor of pediatrics at Rutgers Robert Wood Johnson Medical School and the Embrace Kids Foundation Endowed Chair in Pediatric Hematology/ Oncology, is leading the division's research efforts focused on precision medicine and immunotherapy.

Hugs for Brady

Hugs for Brady Foundation Funds Pediatric Laboratory Space

Recognizing what would have been the 10th birthday of little Brady Wells, Brady's parents Sherrie and Michael Wells - founders of the Hugs for Brady Foundation - have announced a $500,000 pledge from the Foundation to Rutgers Cancer Institute to support a dedicated laboratory space for pediatric cancer research. Led by Rutgers Cancer Institute Chief of Pediatric Hematology/ Oncology Peter D. Cole, MD, work in the newly dedicated Hugs for Brady Foundation Pediatric Cancer Research Lab is focused on immunotherapy and other areas.


Fueling Research Efforts into a Rare T-Cell Cancer

A one-year, $100,000 grant awarded to Rutgers Cancer Institute of New Jersey resident researcher Daniel Herranz Benito, PhD, will support exploration into an aggressive blood cancer that impacts both children and adults - T-cell acute lymphoblastic leukemia (T-ALL). The New Investigator Award from the Leukemia Research Foundation (LRF) is one of 12 awarded nationwide by the entity this year to researchers who are in the early stages of their careers.

stem cells

Exploration of Neural Stem Cell Interactions Aided by $250K Grant

The joint laboratory of Wadih Arap, MD, PhD, director of Rutgers Cancer Institute of New Jersey at University Hospital, and Renata Pasqualini, PhD, chief of the Division of Cancer Biology at Rutgers New Jersey Medical School and Rutgers Cancer Institute, will benefit from a recently awarded $250,000 grant from the Gillson Longenbaugh Foundation. The funding will help expand the team's research focused on two projects: exploring neural stem cell interactions and developing antibody therapeutics for cancer treatment.